Walleye Capital’s Verve Therapeutics VERV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-56,728	Closed	-$277K	–	2895
2024 Q2	$277K	Buy	+56,728	New	+$277K	﹤0.01%	1723
2024 Q1	–	Sell	-17,229	Closed	-$240K	–	3004
2023 Q4	$240K	Buy	+17,229	New	+$240K	﹤0.01%	1432